MARKET

POAI

POAI

Predictive Oncology Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.600
+0.060
+3.90%
Pre Market: 1.680 +0.08 +4.99% 08:38 06/02 EDT
OPEN
1.560
PREV CLOSE
1.540
HIGH
1.655
LOW
1.560
VOLUME
664.33K
TURNOVER
--
52 WEEK HIGH
8.50
52 WEEK LOW
1.250
MARKET CAP
14.60M
P/E (TTM)
-0.2342
1D
5D
1M
3M
1Y
5Y

POAI News

More
Predictive Oncology (NASDAQ Symbol POAI) is licensing and partnering this groundbreaking NSP10 technology in the race to develop a vaccine for development
GlobeNewswire · 05/14 13:30
RIOT, WIX among premarket gainers
Seeking Alpha - Article · 05/14 13:14
APLS, SAVE among premarket losers
Seeking Alpha - Article · 05/07 13:18
Predictive Oncology Announces $2.2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
GlobeNewswire · 05/07 13:00
GM, ATVI among premarket gainers
Seeking Alpha - Article · 05/06 13:23
The Daily Biotech Pulse: FDA Nod For Immunomedics, Lilly's Solid Q1 Beat, Predictive Oncology Restructures Debt
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks htitting 52-week highs April 22.)
Benzinga · 04/23 11:53
Predictive Oncology Exchanges $2.1 Million of Debt for Equity, Streamlining Capital Structure and Simplifying Balance Sheet
GlobeNewswire · 04/22 22:00
Predictive Oncology (NASDAQ: POAI) CEO Discusses Major Asset in Exclusive Interview
GlobeNewswire · 04/22 13:30

Industry

Medical Equipment, Supplies & Distribution
-0.27%
Healthcare Equipment & Supplies
+0.10%

Hot Stocks

Symbol
Price
%Change

About POAI

Predictive Oncology Inc., formerly Precision Therapeutics Inc., is focused on applying artificial intelligence (AI) to personalized medicine and drug discovery. It operates through its three subsidiaries, Helomics Holding Corporation (Helomics), TumorGenesis Inc. and Skyline Medical Inc. Helomics applies AI to its data gathered from patient tumors to both personalize cancer therapies for patients and focusses on the development of new-targeted therapies. Helomics’ clinical laboratory improvement amendments (CLIA)-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions. Its TumorGenesis Inc. is engaged in developing approach to tumors in the laboratory. Skyline Medical Inc. markets its STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions.
More

Webull offers kinds of Predictive Oncology Inc stock information, including NASDAQ:POAI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, POAI stock news, and many more online research tools to help you make informed decisions.